Gap Inc. (NYSE:GPS), the largest US retailer focused on apparel, had a down week after it reported a 2 percent drop in June for sales at stores open at least a year, including online orders. Retail Metrics, a researcher that tracks the industry, had estimated a gain of 0.8 percent. Sales at Gap’s flagship chain…
ACI Worldwide (NASDAQ:ACIW) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a report issued on Monday. The firm currently has a $59.10 price target on the stock. Zacks‘s price objective would indicate a potential upside of 5.54% from the stock’s previous close.ACI Worldwide Inc (NASDAQ:ACIW) stock performance was 32.37% in…
Celladon Corporation (NASDAQ:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, on 07 July 2014 announced that it has launched two new clinical development initiatives for MYDICAR(R), its lead product candidate, in patients with end-stage renal disease (ESRD) undergoing surgery for arteriovenous fistula…
Advanced Micro Devices (NYSE:AMD) was the target of unusually large options trading on Thursday. Traders acquired 28,260 put options on the stock, ARN reports. This is an increase of approximately 255% compared to the typical daily volume of 7,963 put options. Advanced Micro Devices, Inc. (NYSE:AMD) stock performance was 1.42% in last session and finished…
Ford Motor Company (NYSE:F) has a long-term commitment to South Africa, its regional head said, playing down any concerns about strikes that an engineering federation said had prompted the U.S. carmaker to consider pulling out of the country. Ford Motor Company (NYSE:F) stock performance was -0.75% in last session and finished the day at $17.30….
Novogen Limited (ADR) (NASDAQ:NVGN) and CanTx Inc., on June 17, 2014 announced that the proof-of-concept pre-clinical studies were successful. Novogen and its joint venture company CanTx Inc. also gave confirmation of the potency of Intra-Peritoneal Trx-1, their experimental drug. Novogen Limited (ADR) (NASDAQ:NVGN) stock performance was -1.75% in last session and finished the day at…
